BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 25, 2026
Home
»
Topics
»
Disease categories and therapies
» Respiratory
Respiratory
RSS
PDE IV inhibitor SB-207499 in phase II
May 17, 1996
Byk Gulden reports PDE IV inhibitors for asthma, dermatoses
May 17, 1996
Pentoxifylline claimed for treating cold symptoms
May 17, 1996
R-844: Novel steroid for asthma
May 10, 1996
Glaxo Wellcome's newest approach to ARDS
May 3, 1996
Arris announces preliminary results for APC-366
May 3, 1996
Rupatadine poised to enter phase II
May 3, 1996
New Glaxo Wellcome compounds protect against leukocyte-induced tissue damage
April 26, 1996
TAC-363 pharmacological profile presented
April 26, 1996
Merck Frosst's new generation of 5-LO inhibitors
April 26, 1996
Previous
1
2
…
730
731
732
733
734
735
736
737
738
Next
RSS